Search results
Results From The WOW.Com Content Network
The industry is fragmented, with the top 10 companies controlling 56% of the market in 2008 [10] and 55% in 2009. [11] In 2018 global CRO market stood at $38,396.4 mln. and is projected to reach $90,926.3 mln. by the end of 2026, exhibiting a CAGR of 11.4% in the forecast period. [12
Life sciences, along with energy, agriculture, manufacturing, and robotics and technology, are one of five pillars of his economic investment strategy. The budget outlines a $65 million investment ...
The biotechnology industry in Boston dates back to the 1970s, when genetic engineering was developing. Biogen was the first company in Boston to focus on biotechnology. [6] [7] In 2008, Massachusetts Governor Deval Patrick announced the Massachusetts Life Sciences Act, promising $1 billion to further the development of the biotech industry.
The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million to help launch 15 to 20 ventures in life sciences and biotechnology in 2014, [6] and in January 2018, the City of New ...
Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. Headquartered in Pleasanton, California, it was founded in 2007 by Peter Gassner and Matt Wallach. It operates with software as a service (SaaS) company in the life-science industry. [3]
The occupational employment projections, along with other information about occupations, are published in the Occupational Outlook Handbook and the National Employment Matrix. The 10-year projections cover economic growth, employment by industry and occupation, and labor force. They are widely used in career guidance, in planning education and ...
You asked about other markets, medical, which is a big bag of medical businesses, including pharmaceutical, life science, medical device representing about 10% of our business overall.
The initiative received a major boost in 2001 when money from the state's settlement with the tobacco industry was pledged to create a life science greenhouse in Western Pennsylvania. [3] In 2003, Pittsburgh Biomedical Corporation, a non-profit established in 1988 by the Pittsburgh Technology Council, consolidated with PLSG.